News

Aspirin Not Cardioprotective in Type 2 Diabetes


 

“We may need to rethink the guidelines,” she suggested, “especially for patients younger than 65.”

Pages

Recommended Reading

Intensive Control Offers Little Benefit for Vision
MDedge Endocrinology
Candesartan Has DIRECT Effects on Retinopathy
MDedge Endocrinology
Culturally Based Diabetes Education Aids Glycemic Control
MDedge Endocrinology
Cardiovascular Disease Is 'Next Frontier' in Type 1
MDedge Endocrinology
Liraglutide Helps Reduce Body Weight, HbA1c
MDedge Endocrinology
Prasugrel's Ischemic Benefit Enhanced in Diabetes
MDedge Endocrinology
Long-Term Outlook Brighter for Type 1 Patients
MDedge Endocrinology
Diabetes Medicine Guide in Spanish
MDedge Endocrinology
Aggressive Hypertension Tx in Diabetes Urged
MDedge Endocrinology
Plasma Vitamin C Level Indicates Diabetes Risk
MDedge Endocrinology